Inhibition of gastric acid secretion and ulcer formation in the rat by orally-administered 11-deoxyprostaglandin analogues: 15-hydroxy-16,16-dimethyl-9-oxoprost-5,13-dienoic acids.
D000284:Administration, Oral; D000818:Animals; D003864:Depression, Chemical; D003967:Diarrhea / Q000139:chemically induced; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D005750:Gastric Juice / Q000378:metabolism*; D005753:Gastric Mucosa / Q000187:drug effects*; D007213:Indomethacin; D007536:Isomerism; D008026:Ligation; D011453:Prostaglandins / Q000008:administration & dosage / Q000494:pharmacology*; D011708:Pylorus / Q000502:physiology; D051381:Rats; D012636:Secretory Rate / Q000187:drug effects; D013276:Stomach Ulcer / Q000139:chemically induced / Q000378:metabolism*
D005231:Fatty Acids, Unsaturated; D011453:Prostaglandins; D007213:Indomethacin